ACTU — Actuate Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing
Brief: Actuate Therapeutics Announces Closing Of $17.25 Million Public Offering Of Common Stock, Including Full Exercise Of Over-Allotment Option
Brief: Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
Brief: Actuate Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Actuate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $250 Million- SEC Filing
U.S. RESEARCH ROUNDUP- CBRE Group, Horizon Bancorp, Ulta Beauty
Brief: Actuate Therapeutics- To Collaborate With Incyte Corporation On Clinical Trials
Brief: Actuate Therapeutics Highlights Survival Benefit In Metastatic Pancreatic Cancer Patient Populations
U.S. STOCKS ON THE MOVE-Leidos, Gartner, EVgo
U.S. STOCKS ON THE MOVE-Duke Energy, Leidos, Gartner
U.S. STOCKS ON THE MOVE-Datadog, Marriott, IQVIA
Actuate rises as pancreatic cancer drug succeeds in mid-stage trial
Brief: Actuate Therapeutics Enters Stock Purchase Agreement With B. Riley Principal Capital Ii, Llc
Brief: Actuate Therapeutics Files Prospectus To Offer, Sale Of Up To 3.9 Million Shares By B. Riley Principal Capital II, LLC
U.S. STOCKS ON THE MOVE-Blackstone, PepsiCo, Blue Owl Capital
U.S. STOCKS ON THE MOVE-Gold miners, Blackstone, PepsiCo